Printer Friendly

HIV Panel completes report.

HIV panel completes report

The Presidential Commission on the Human Immunodeficiency Virus (HIV) Epidemic, in finishing its final report last week, recommended freeing the National Institutes of Health's efforts to oversee AIDS research from the strict supervision of the Office of Management and budget. The 13-member panel also suggested that manufacturers of an AIDS vaccine and physicians who test it be protected from excessive legal liability.

After reviewing public comments on their draft report, commissioners added a recommendation for a registry to hold findings from clinical trials.

The 300-page document emphasizes that public health officials should devote their attention to the entire spectrum of HIV virus infection, not just to people who have developed the disease.

"Did everybody note that we have just achieved a major milestone?" remarked chairman James Watkins as commissioners approved the 11th chapter of the 300-page report due on President Reagan's desk June 24. Deleted from the final report were Watkins' stern criticisms of the federal government's handling of the epidemic (SN: 6/11/88, p.372).
COPYRIGHT 1988 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1988, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Presidential Commission on the Human Immunodeficiency Virus Epidemic
Publication:Science News
Date:Jun 25, 1988
Previous Article:AIDS meeting suggests basic research gaps.
Next Article:Scheduling science aboard the shuttle.

Related Articles
Pessimistic outlook in AIDS reports.
HIV ancestry traced in family tree.
HIV and IV drug abuse: AIDS poses a growing threat to addicts, and thus to society as a whole.
Children with AIDS.
Development of a mouse model for HIV/AIDS.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters